PFDN5 and colorectal carcinoma: KDM5C is overexpressed in CRC cells and clinical samples, where it mediates the demethylation of H3K4me3 on the PFDN5 promoter, inhibiting its transcription and promoting the malignant phenotype of CRC [9].